Mycobacterium avium complex pulmonary disease
Clinical trials for Mycobacterium avium complex pulmonary disease explained in plain language.
Never miss a new study
Get alerted when new Mycobacterium avium complex pulmonary disease trials appear
Sign up with your email to follow new studies for Mycobacterium avium complex pulmonary disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Three-Drug cocktail clear a stubborn lung infection?
Disease control Recruiting nowResearchers are following 100 people newly diagnosed with Mycobacterium avium complex pulmonary disease (MAC-PD) who need standard three-drug antibiotic treatment. The study measures how many patients clear the infection after six months, how their bacterial load changes, and how…
Matched conditions: MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibiotic combo aims to cut treatment time for stubborn lung infection
Disease control Recruiting nowThis study tests whether adding the antibiotic contezolid to standard drugs can shorten treatment for Mycobacterium Avium Complex (MAC) lung disease. About 188 adults with the nodular bronchiectatic form of the disease will either receive contezolid plus standard therapy for 6 mo…
Matched conditions: MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE
Phase 4 • Sponsor: Bin Cao • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug combo aims to knock out stubborn lung bug
Disease control Recruiting nowThis study tests whether adding the antibiotic contezolid to the usual three-drug regimen can better reduce bacteria in the sputum of adults with Mycobacterium avium complex (MAC) lung disease. About 188 participants will receive either the standard treatment alone or with contez…
Matched conditions: MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE
Phase 4 • Sponsor: Bin Cao • Aim: Disease control
Last updated Jun 26, 2026 18:25 UTC
-
Mushroom extract tested to stop lung infection relapse
Prevention Recruiting nowThis study tests whether a daily cordyceps sinensis capsule (Bailiing Capsule) can prevent the recurrence of Mycobacterium avium complex (MAC) lung disease in adults who have already been cured. 300 participants will take either the cordyceps capsule or a placebo for 12 months, w…
Matched conditions: MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE
Phase 4 • Sponsor: Bin Cao • Aim: Prevention
Last updated Jun 26, 2026 17:15 UTC